Primary Hyperparathyroidism: Does a Systematic Treatment Improve the Calcium- and Bone Metabolism After Successful Surgery? - Part I

NCT01222026 Phase 4 COMPLETED

Patients with primary hyperparathyroidism (pHPT) with osteopenia and osteoporosis are treated with strontium ranelate/Ca+Vitamin-D or placebo/Ca+Vitamin D after successful surgical treatment of pHPT. Strontium ranelate/Ca + Vitamin-D helps to regain bone mass in patients with osteopenia or osteoporosis after successful parathyroidectomy for pHPT and results in higher gain of BMD than placebo treated patients.

Details

Lead sponsor	Medical University of Vienna
Phase	Phase 4
Status	COMPLETED
Enrolment	63
Start date	2010-09
Completion	2014-12

Conditions

• Primary Hyperparathyroidism
• Osteopenia
• Osteoporosis

Interventions

• Strontium Ranelate + Ca/Vitamin-D
• Placebo

Primary outcomes

• Bone mineral density measurement of the Lumbar spine — 1 year

Countries

Austria